InsiderTradesSIGMA

PicksTOP Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FRUSDEGBCHCAITESNLBENOSEFIDKAUATIEBRINJP+ 8 markets

Recommendations
Companies
Insiders
Performance
Backtest
Compare

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

Theme: dark (range regime detected on CAC40 90d · as of 2026-05-22)

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

All systems operational

InsidersTradesSigma

Amit Mahla — reported transactions · 16 filings

← Executives ★ Sign in to follow

AM

Amit Mahla

ININ·SEBI (PIT + SAST)

JB Chemicals & Pharmaceuticals Limited

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Browse the detailed record of transactions filed by Amit Mahla. Insider active across 1 companies, notably JB Chemicals & Pharmaceuticals Limited. Cumulatively, 16 disclosures have been logged. The latest transaction was filed on 23 January 2026 — Pledge. Regulator: SEBI (PIT + SAST). The full history is free.

Declarations16 total

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

A

€556,20937,440 shares@ €14.856

Equity Shares

SEBI:fae01ad895c2ea7fc9abfadda9e9ad9f42c54afc·23 Jan 2026

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

A

€556,20937,440 shares@ €14.856

Equity Shares

SEBI:55a748118978f0ac207a65b193fd853ac8350fe7·23 Jan 2026

Executives●SaleJJB Chemicals & Pharmaceuticals Limited0SEBI

A

€556,20937,440 shares@ €14.856

Equity Shares

SEBI:a904a11b57312a65378c65b50fa8ff395d96c342·23 Jan 2026

Executives●PurchaseJJB Chemicals & Pharmaceuticals Limited0SEBI

A

€659,80137,440 shares@ €17.6229

Equity Shares

SEBI:084fdbb667b2b7fede05bbc87d105da0dfde7f17·21 Jan 2026

Ideal exit: 18 Oct 2026 (T+270)

Executives●PurchaseJJB Chemicals & Pharmaceuticals Limited0SEBI

A

€103,4326,183 shares@ €16.7284

Equity Shares

SEBI:bfdbfff8f59a455ccafb7900238f65449e8cbc20·14 Aug 2025

Ideal exit: 11 May 2026 (T+270)

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

A

€22,0951,280 shares@ €17.2621

Equity Shares

SEBI:996e9a8b21b652a77a815bb65d85cebfa4cff3e9·10 Jun 2025

Executives●PurchaseJJB Chemicals & Pharmaceuticals Limited0SEBI

A

€22,2681,280 shares@ €17.3967

Equity Shares

SEBI:c24f27612f6f9bdb406dc4846b707796778bee1f·5 Jun 2025

Ideal exit: 2 Mar 2026 (T+270)

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

A

€30,5491,760 shares@ €17.3575

Equity Shares

SEBI:8484fc166ae6bc226ef85de3c94a292601f88b36·6 Mar 2025

Executives●SaleJJB Chemicals & Pharmaceuticals Limited0SEBI

A

€30,5491,760 shares@ €17.3575

Equity Shares

SEBI:7f870f9451ece085eba4a8bac5e819f686d0eaaa·6 Mar 2025

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

A

€31,0121,760 shares@ €17.6205

Equity Shares

SEBI:2a3043a50f82852058558b4877a4dfd819272d8d·4 Mar 2025

Executives●PurchaseJJB Chemicals & Pharmaceuticals Limited0SEBI

A

€30,3571,760 shares@ €17.2485

Equity Shares

SEBI:5de8ff1b98bf3f4ff2bdf5ad58140ab4b0068c3e·27 Feb 2025

Ideal exit: 24 Nov 2025 (T+270)

Executives●SaleJJB Chemicals & Pharmaceuticals Limited0SEBI

A

€42,0712,000 shares@ €21.0355

Equity Shares

SEBI:ec9fdbe7cd9b21b7046de3fc726985281dba4fd1·30 Aug 2024

Executives●SaleJJB Chemicals & Pharmaceuticals Limited0SEBI

A

€41,5802,000 shares@ €20.7899

Equity Shares

SEBI:a5f4cf29687b85817676bd37dd9eaa0c3a753d29·30 Aug 2024

Executives●PurchaseJJB Chemicals & Pharmaceuticals Limited0SEBI

A

€81,1934,000 shares@ €20.2983

Equity Shares

SEBI:bdc7d6fdb584b050f8ed202cf289d2196366fd9d·26 Aug 2024

Ideal exit: 23 May 2025 (T+270)

Executives●SaleJJB Chemicals & Pharmaceuticals Limited0SEBI

A

€30,6651,920 shares@ €15.9712

Equity Shares

SEBI:6316a93a027d750ce298c2f1110862277dd3b990·28 Sept 2023

Executives●PurchaseJJB Chemicals & Pharmaceuticals Limited0SEBI

A

€27,938960 shares@ €29.1016

Equity Shares

SEBI:54e635dccc595a6a7e91486d92a42d6019e2c05b·13 Aug 2023

Ideal exit: 9 May 2024 (T+270)

16 of 16 declarations